Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Sirolimus as Part of Immunosuppressive Therapy for Refractory Chronic Graft-versus-Host Disease

Published:2007-06 Issue:6 Volume:13 Page:701-706
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jurado Manuel,Vallejo Carlos,Pérez-Simón José A.,Brunet Salut,Ferra Christelle,Balsalobre Pascual,Pérez-Oteyza Jaime,Espigado Ildefonso,Romero Antonio,Caballero Dolores,Sierra Jorge,Ribera Jose M.,Díez Jose L.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Health and functional status of long-term survivors of bone marrow transplantation;Duell;Ann Intern Med,1997

2. Long-term survival and late deaths after allogeneic bone marrow transplantation;Socie;N Engl J Med,1999

3. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone;Koc;Blood,2002

4. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease;Sullivan;Blood,1988

5. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease;Lopez;Biol Blood Marrow Transplant,2005

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study;Bone Marrow Transplantation;2024-05-02

2. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development;Current Oncology;2024-03-08

3. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience;Istanbul Medical Journal;2023-05-31

4. Chronic graft-versus-host disease. Part II: disease activity grading and therapeutic management;Journal of the American Academy of Dermatology;2022-12

5. Chronic graft-vs-host disease: Current understanding of disease and treatment landscape;Journal of Managed Care & Specialty Pharmacy;2022-12